730500login-checkGrowth hormone lowers liver fat for adults with obesity, steatotic liver disease |
By Michael Monostra
Adults with overweight or obesity and metabolic dysfunction-associated steatotic liver disease had a more than 5% reduction in liver fat at 6 months with growth hormone therapy, according to findings from a randomized controlled trial.
“Specifically, GH significantly decreased liver fat and alanine aminotransferase as well as visceral adipose tissue and high sensitivity C-reactive protein,” Laura Dichtel, MD, MHS, endocrinologist and assistant professor at Harvard Medical School and the director of steatotic liver disease research in the neuroendocrine unit at Massachusetts General Hospital, told Healio. Read the full story in Healio.
730500login-checkGrowth hormone lowers liver fat for adults with obesity, steatotic liver disease |